Linda Wietecha

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

Peter J. Goadsby, Linda Wietecha, Ellen B. Dennehy et al. · Brain · 2019 · 275 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 267 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

Michael Dougan, Masoud Azizad, Peter Chen et al. · medRxiv · 2022 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

Joel Young, Elias Sarkis, Meihua Qiao et al. · Clinical Neuropharmacology · 2011 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +16

Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial

Linda Wietecha, David W. Williams, Sally E. Shaywitz et al. · Journal of Child and Adolescent Psychopharmacology · 2013 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17